The Clinical Role of VITRAKVI (larotrectinib): Presentation on NTRK Gene Fusions ~ 10/5/22 Oct 3, 20221 min readEmail Adnan directly at adnan.masri@bayer.com! Full flyer info: BAY0010025 Invite (digital)10-5-22.pdfDownload PDF • 321KB
NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress
NEW EVENT! An Approved Trop2-Directed ADC forAdults With Previously Treated HR+/HER2–(IHC 0, IHC 1+ or IHC 2+/ISH–) MetastaticBreast Cancer - May 13th!
Comments